nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—primary biliary cirrhosis	0.466	1	CbGaD
Eprosartan—ABCC2—Ursodeoxycholic acid—primary biliary cirrhosis	0.239	0.81	CbGbCtD
Eprosartan—CYP2C9—Colchicine—primary biliary cirrhosis	0.0562	0.19	CbGbCtD
Eprosartan—ABCC2—bile canaliculus—primary biliary cirrhosis	0.0408	0.586	CbGeAlD
Eprosartan—ABCC2—bile duct—primary biliary cirrhosis	0.0128	0.183	CbGeAlD
Eprosartan—ABCC2—bile—primary biliary cirrhosis	0.0098	0.141	CbGeAlD
Eprosartan—ABCC2—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00689	0.151	CbGpPWpGaD
Eprosartan—ABCC2—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00522	0.114	CbGpPWpGaD
Eprosartan—AGTR1—ACE Inhibitor Pathway—MAS1—primary biliary cirrhosis	0.0048	0.105	CbGpPWpGaD
Eprosartan—AGTR1—ACE Inhibitor Pathway—ACE2—primary biliary cirrhosis	0.00364	0.0798	CbGpPWpGaD
Eprosartan—AGTR1—ACE Inhibitor Pathway—REN—primary biliary cirrhosis	0.00276	0.0605	CbGpPWpGaD
Eprosartan—Retrosternal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00259	0.0214	CcSEcCtD
Eprosartan—Retrosternal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00259	0.0214	CcSEcCtD
Eprosartan—AGTR1—epithelium—primary biliary cirrhosis	0.00195	0.028	CbGeAlD
Eprosartan—AGTR1—smooth muscle tissue—primary biliary cirrhosis	0.00188	0.0269	CbGeAlD
Eprosartan—AGTR1—ACE Inhibitor Pathway—ACE—primary biliary cirrhosis	0.00172	0.0377	CbGpPWpGaD
Eprosartan—ABCC2—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00156	0.0343	CbGpPWpGaD
Eprosartan—Neuritis—Colchicine—primary biliary cirrhosis	0.00156	0.0128	CcSEcCtD
Eprosartan—Influenza-like symptoms—Ursodeoxycholic acid—primary biliary cirrhosis	0.00146	0.0121	CcSEcCtD
Eprosartan—Influenza-like symptoms—Chenodeoxycholic acid—primary biliary cirrhosis	0.00146	0.0121	CcSEcCtD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00138	0.0302	CbGpPWpGaD
Eprosartan—Otitis media—Ursodeoxycholic acid—primary biliary cirrhosis	0.00134	0.0111	CcSEcCtD
Eprosartan—Otitis media—Chenodeoxycholic acid—primary biliary cirrhosis	0.00134	0.0111	CcSEcCtD
Eprosartan—Rhabdomyolysis—Colchicine—primary biliary cirrhosis	0.00131	0.0108	CcSEcCtD
Eprosartan—Gout—Colchicine—primary biliary cirrhosis	0.00125	0.0103	CcSEcCtD
Eprosartan—Losartan—ACE—primary biliary cirrhosis	0.00116	0.709	CrCbGaD
Eprosartan—Viral infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00954	CcSEcCtD
Eprosartan—Viral infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00954	CcSEcCtD
Eprosartan—Herpes simplex—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00935	CcSEcCtD
Eprosartan—Herpes simplex—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00935	CcSEcCtD
Eprosartan—AGTR1—liver—primary biliary cirrhosis	0.0011	0.0158	CbGeAlD
Eprosartan—Bone pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00899	CcSEcCtD
Eprosartan—Bone pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00899	CcSEcCtD
Eprosartan—AGTR1—ACE Inhibitor Pathway—AGT—primary biliary cirrhosis	0.00109	0.0239	CbGpPWpGaD
Eprosartan—Rash maculo-papular—Colchicine—primary biliary cirrhosis	0.00106	0.00871	CcSEcCtD
Eprosartan—Bladder pain—Colchicine—primary biliary cirrhosis	0.00105	0.00867	CcSEcCtD
Eprosartan—Cystitis noninfective—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00841	CcSEcCtD
Eprosartan—Cystitis noninfective—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00841	CcSEcCtD
Eprosartan—Influenza like illness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00837	CcSEcCtD
Eprosartan—Influenza like illness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00837	CcSEcCtD
Eprosartan—Cystitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00832	CcSEcCtD
Eprosartan—Urinary incontinence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00832	CcSEcCtD
Eprosartan—Urinary incontinence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00832	CcSEcCtD
Eprosartan—Cystitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00832	CcSEcCtD
Eprosartan—AGTR1—Peptide GPCRs—CXCR5—primary biliary cirrhosis	0.000988	0.0217	CbGpPWpGaD
Eprosartan—Cramps of lower extremities—Ursodeoxycholic acid—primary biliary cirrhosis	0.00096	0.00791	CcSEcCtD
Eprosartan—Cramps of lower extremities—Chenodeoxycholic acid—primary biliary cirrhosis	0.00096	0.00791	CcSEcCtD
Eprosartan—Oesophagitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000955	0.00787	CcSEcCtD
Eprosartan—Oesophagitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000955	0.00787	CcSEcCtD
Eprosartan—Bladder pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000945	0.00779	CcSEcCtD
Eprosartan—Bladder pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000945	0.00779	CcSEcCtD
Eprosartan—Vascular purpura—Colchicine—primary biliary cirrhosis	0.000944	0.00778	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—CXCR5—primary biliary cirrhosis	0.000937	0.0206	CbGpPWpGaD
Eprosartan—Abnormal vision—Chenodeoxycholic acid—primary biliary cirrhosis	0.000912	0.00751	CcSEcCtD
Eprosartan—Abnormal vision—Ursodeoxycholic acid—primary biliary cirrhosis	0.000912	0.00751	CcSEcCtD
Eprosartan—Purpura—Colchicine—primary biliary cirrhosis	0.000876	0.00722	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—CXCL9—primary biliary cirrhosis	0.000851	0.0187	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL12A—primary biliary cirrhosis	0.000828	0.0182	CbGpPWpGaD
Eprosartan—Atrial fibrillation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000801	0.0066	CcSEcCtD
Eprosartan—Atrial fibrillation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000801	0.0066	CcSEcCtD
Eprosartan—ABCC2—liver—primary biliary cirrhosis	0.000798	0.0115	CbGeAlD
Eprosartan—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.000791	0.00652	CcSEcCtD
Eprosartan—Arthritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000781	0.00643	CcSEcCtD
Eprosartan—Arthritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000781	0.00643	CcSEcCtD
Eprosartan—Cardiac failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000777	0.00641	CcSEcCtD
Eprosartan—Cardiac failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000777	0.00641	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00076	0.00627	CcSEcCtD
Eprosartan—Migraine—Chenodeoxycholic acid—primary biliary cirrhosis	0.000747	0.00616	CcSEcCtD
Eprosartan—Migraine—Ursodeoxycholic acid—primary biliary cirrhosis	0.000747	0.00616	CcSEcCtD
Eprosartan—Muscular weakness—Colchicine—primary biliary cirrhosis	0.000745	0.00614	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.000745	0.00614	CcSEcCtD
Eprosartan—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000732	0.00604	CcSEcCtD
Eprosartan—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000732	0.00604	CcSEcCtD
Eprosartan—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000711	0.00586	CcSEcCtD
Eprosartan—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000711	0.00586	CcSEcCtD
Eprosartan—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000693	0.00571	CcSEcCtD
Eprosartan—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000693	0.00571	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000683	0.00563	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000683	0.00563	CcSEcCtD
Eprosartan—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000671	0.00553	CcSEcCtD
Eprosartan—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000671	0.00553	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000669	0.00552	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000669	0.00552	CcSEcCtD
Eprosartan—Asthma—Ursodeoxycholic acid—primary biliary cirrhosis	0.000656	0.0054	CcSEcCtD
Eprosartan—Asthma—Chenodeoxycholic acid—primary biliary cirrhosis	0.000656	0.0054	CcSEcCtD
Eprosartan—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.000639	0.00526	CcSEcCtD
Eprosartan—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.000639	0.00526	CcSEcCtD
Eprosartan—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.000638	0.00526	CcSEcCtD
Eprosartan—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000631	0.0052	CcSEcCtD
Eprosartan—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000631	0.0052	CcSEcCtD
Eprosartan—Haematuria—Colchicine—primary biliary cirrhosis	0.00062	0.00511	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000609	0.00502	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000609	0.00502	CcSEcCtD
Eprosartan—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000606	0.00499	CcSEcCtD
Eprosartan—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000606	0.00499	CcSEcCtD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000604	0.0133	CbGpPWpGaD
Eprosartan—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.000583	0.00481	CcSEcCtD
Eprosartan—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.000583	0.00481	CcSEcCtD
Eprosartan—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000575	0.00474	CcSEcCtD
Eprosartan—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000575	0.00474	CcSEcCtD
Eprosartan—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000568	0.00468	CcSEcCtD
Eprosartan—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000568	0.00468	CcSEcCtD
Eprosartan—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000568	0.00468	CcSEcCtD
Eprosartan—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000568	0.00468	CcSEcCtD
Eprosartan—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000557	0.00459	CcSEcCtD
Eprosartan—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000557	0.00459	CcSEcCtD
Eprosartan—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000551	0.00455	CcSEcCtD
Eprosartan—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000551	0.00455	CcSEcCtD
Eprosartan—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000549	0.00452	CcSEcCtD
Eprosartan—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000549	0.00452	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.000545	0.012	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RPS6KB1—primary biliary cirrhosis	0.000533	0.0117	CbGpPWpGaD
Eprosartan—CYP2C9—liver—primary biliary cirrhosis	0.000531	0.00763	CbGeAlD
Eprosartan—ABCC2—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000527	0.0116	CbGpPWpGaD
Eprosartan—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000526	0.00434	CcSEcCtD
Eprosartan—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000526	0.00434	CcSEcCtD
Eprosartan—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000521	0.00429	CcSEcCtD
Eprosartan—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000521	0.00429	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—IL12B—primary biliary cirrhosis	0.00052	0.0114	CbGpPWpGaD
Eprosartan—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000517	0.00426	CcSEcCtD
Eprosartan—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000517	0.00426	CcSEcCtD
Eprosartan—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.000506	0.00417	CcSEcCtD
Eprosartan—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.000506	0.00417	CcSEcCtD
Eprosartan—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000489	0.00403	CcSEcCtD
Eprosartan—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000489	0.00403	CcSEcCtD
Eprosartan—Muscle spasms—Colchicine—primary biliary cirrhosis	0.000489	0.00403	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—CTLA4—primary biliary cirrhosis	0.000489	0.0107	CbGpPWpGaD
Eprosartan—Losartan—ALB—primary biliary cirrhosis	0.000477	0.291	CrCbGaD
Eprosartan—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.000471	0.00388	CcSEcCtD
Eprosartan—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.000471	0.00388	CcSEcCtD
Eprosartan—Angioedema—Colchicine—primary biliary cirrhosis	0.000465	0.00383	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCR5—primary biliary cirrhosis	0.000464	0.0102	CbGpPWpGaD
Eprosartan—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00045	0.00371	CcSEcCtD
Eprosartan—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00045	0.00371	CcSEcCtD
Eprosartan—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000448	0.0037	CcSEcCtD
Eprosartan—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000448	0.0037	CcSEcCtD
Eprosartan—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000444	0.00366	CcSEcCtD
Eprosartan—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000444	0.00366	CcSEcCtD
Eprosartan—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000442	0.00364	CcSEcCtD
Eprosartan—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000442	0.00364	CcSEcCtD
Eprosartan—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.000439	0.00362	CcSEcCtD
Eprosartan—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.000439	0.00362	CcSEcCtD
Eprosartan—Myalgia—Colchicine—primary biliary cirrhosis	0.000433	0.00357	CcSEcCtD
Eprosartan—Arthralgia—Colchicine—primary biliary cirrhosis	0.000433	0.00357	CcSEcCtD
Eprosartan—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000424	0.00349	CcSEcCtD
Eprosartan—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000424	0.00349	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL9—primary biliary cirrhosis	0.000422	0.00925	CbGpPWpGaD
Eprosartan—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000417	0.00344	CcSEcCtD
Eprosartan—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000417	0.00344	CcSEcCtD
Eprosartan—CYP2C9—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000417	0.00914	CbGpPWpGaD
Eprosartan—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000412	0.0034	CcSEcCtD
Eprosartan—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000412	0.0034	CcSEcCtD
Eprosartan—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.000411	0.00338	CcSEcCtD
Eprosartan—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.000411	0.00338	CcSEcCtD
Eprosartan—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.00041	0.00338	CcSEcCtD
Eprosartan—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.00041	0.00338	CcSEcCtD
Eprosartan—Shock—Colchicine—primary biliary cirrhosis	0.000408	0.00337	CcSEcCtD
Eprosartan—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000406	0.00335	CcSEcCtD
Eprosartan—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.000404	0.00333	CcSEcCtD
Eprosartan—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.000404	0.00333	CcSEcCtD
Eprosartan—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000402	0.00331	CcSEcCtD
Eprosartan—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000402	0.00331	CcSEcCtD
Eprosartan—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000399	0.00329	CcSEcCtD
Eprosartan—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000399	0.00329	CcSEcCtD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000397	0.00871	CbGpPWpGaD
Eprosartan—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000389	0.00321	CcSEcCtD
Eprosartan—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000389	0.00321	CcSEcCtD
Eprosartan—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000389	0.00321	CcSEcCtD
Eprosartan—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000389	0.00321	CcSEcCtD
Eprosartan—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000389	0.00321	CcSEcCtD
Eprosartan—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000389	0.00321	CcSEcCtD
Eprosartan—Hypotension—Colchicine—primary biliary cirrhosis	0.000388	0.0032	CcSEcCtD
Eprosartan—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000384	0.00317	CcSEcCtD
Eprosartan—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000384	0.00317	CcSEcCtD
Eprosartan—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00038	0.00314	CcSEcCtD
Eprosartan—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00038	0.00314	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—CD40LG—primary biliary cirrhosis	0.00038	0.00834	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000378	0.00312	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—IL4—primary biliary cirrhosis	0.00037	0.00811	CbGpPWpGaD
Eprosartan—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000367	0.00302	CcSEcCtD
Eprosartan—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000367	0.00302	CcSEcCtD
Eprosartan—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000365	0.00301	CcSEcCtD
Eprosartan—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000365	0.00301	CcSEcCtD
Eprosartan—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000364	0.003	CcSEcCtD
Eprosartan—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000364	0.003	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000364	0.00798	CbGpPWpGaD
Eprosartan—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000361	0.00297	CcSEcCtD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—primary biliary cirrhosis	0.000361	0.00791	CbGpPWpGaD
Eprosartan—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00036	0.00297	CcSEcCtD
Eprosartan—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00036	0.00297	CcSEcCtD
Eprosartan—Fatigue—Colchicine—primary biliary cirrhosis	0.000358	0.00295	CcSEcCtD
Eprosartan—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000355	0.00293	CcSEcCtD
Eprosartan—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000355	0.00293	CcSEcCtD
Eprosartan—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000348	0.00287	CcSEcCtD
Eprosartan—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000348	0.00287	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00034	0.0028	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00034	0.0028	CcSEcCtD
Eprosartan—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000339	0.0028	CcSEcCtD
Eprosartan—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000337	0.00278	CcSEcCtD
Eprosartan—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000337	0.00278	CcSEcCtD
Eprosartan—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000335	0.00276	CcSEcCtD
Eprosartan—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000335	0.00276	CcSEcCtD
Eprosartan—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000332	0.00274	CcSEcCtD
Eprosartan—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000332	0.00274	CcSEcCtD
Eprosartan—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000332	0.00273	CcSEcCtD
Eprosartan—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000332	0.00273	CcSEcCtD
Eprosartan—Urticaria—Colchicine—primary biliary cirrhosis	0.00033	0.00272	CcSEcCtD
Eprosartan—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000328	0.00271	CcSEcCtD
Eprosartan—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000328	0.00271	CcSEcCtD
Eprosartan—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000328	0.0027	CcSEcCtD
Eprosartan—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000324	0.00267	CcSEcCtD
Eprosartan—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000324	0.00267	CcSEcCtD
Eprosartan—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000321	0.00265	CcSEcCtD
Eprosartan—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000321	0.00265	CcSEcCtD
Eprosartan—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000319	0.00263	CcSEcCtD
Eprosartan—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000319	0.00263	CcSEcCtD
Eprosartan—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000319	0.00263	CcSEcCtD
Eprosartan—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000319	0.00263	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000312	0.00683	CbGpPWpGaD
Eprosartan—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000307	0.00253	CcSEcCtD
Eprosartan—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000307	0.00253	CcSEcCtD
Eprosartan—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000306	0.00252	CcSEcCtD
Eprosartan—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000305	0.00251	CcSEcCtD
Eprosartan—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000305	0.00251	CcSEcCtD
Eprosartan—Asthenia—Colchicine—primary biliary cirrhosis	0.000298	0.00245	CcSEcCtD
Eprosartan—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000296	0.00244	CcSEcCtD
Eprosartan—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000296	0.00244	CcSEcCtD
Eprosartan—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000295	0.00243	CcSEcCtD
Eprosartan—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000295	0.00243	CcSEcCtD
Eprosartan—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000295	0.00243	CcSEcCtD
Eprosartan—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000295	0.00243	CcSEcCtD
Eprosartan—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000284	0.00234	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000283	0.00621	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CD80—primary biliary cirrhosis	0.000283	0.0062	CbGpPWpGaD
Eprosartan—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000275	0.00226	CcSEcCtD
Eprosartan—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000275	0.00226	CcSEcCtD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—primary biliary cirrhosis	0.000268	0.00588	CbGpPWpGaD
Eprosartan—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000268	0.00221	CcSEcCtD
Eprosartan—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000268	0.00221	CcSEcCtD
Eprosartan—Vomiting—Colchicine—primary biliary cirrhosis	0.000264	0.00217	CcSEcCtD
Eprosartan—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000264	0.00217	CcSEcCtD
Eprosartan—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000264	0.00217	CcSEcCtD
Eprosartan—Rash—Colchicine—primary biliary cirrhosis	0.000262	0.00216	CcSEcCtD
Eprosartan—Dermatitis—Colchicine—primary biliary cirrhosis	0.000261	0.00215	CcSEcCtD
Eprosartan—Headache—Colchicine—primary biliary cirrhosis	0.00026	0.00214	CcSEcCtD
Eprosartan—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000255	0.0021	CcSEcCtD
Eprosartan—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000255	0.0021	CcSEcCtD
Eprosartan—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000247	0.00203	CcSEcCtD
Eprosartan—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000247	0.00203	CcSEcCtD
Eprosartan—Nausea—Colchicine—primary biliary cirrhosis	0.000247	0.00203	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000237	0.0052	CbGpPWpGaD
Eprosartan—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000237	0.00195	CcSEcCtD
Eprosartan—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000237	0.00195	CcSEcCtD
Eprosartan—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000235	0.00194	CcSEcCtD
Eprosartan—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000235	0.00194	CcSEcCtD
Eprosartan—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000235	0.00194	CcSEcCtD
Eprosartan—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000235	0.00194	CcSEcCtD
Eprosartan—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000234	0.00193	CcSEcCtD
Eprosartan—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000234	0.00193	CcSEcCtD
Eprosartan—CYP2C9—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000232	0.00508	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000227	0.00497	CbGpPWpGaD
Eprosartan—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000221	0.00183	CcSEcCtD
Eprosartan—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000221	0.00183	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.00022	0.00482	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000215	0.00473	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000189	0.00415	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.000182	0.00399	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.000182	0.00398	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000176	0.00386	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.00016	0.00351	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.000158	0.00347	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000147	0.00323	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.000143	0.00314	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000134	0.00294	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000127	0.00278	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000122	0.00267	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000122	0.00267	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000112	0.00246	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000111	0.00242	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.000107	0.00235	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000106	0.00233	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000105	0.0023	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL5—primary biliary cirrhosis	9.66e-05	0.00212	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	9.41e-05	0.00206	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	8.25e-05	0.00181	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—AGT—primary biliary cirrhosis	8.08e-05	0.00177	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	7.67e-05	0.00168	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CDH5—primary biliary cirrhosis	7.47e-05	0.00164	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCR5—primary biliary cirrhosis	7.19e-05	0.00158	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—GGT1—primary biliary cirrhosis	6.78e-05	0.00149	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL9—primary biliary cirrhosis	6.53e-05	0.00143	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	6.34e-05	0.00139	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	6.34e-05	0.00139	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ELMO1—primary biliary cirrhosis	6.04e-05	0.00133	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	5.76e-05	0.00126	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	5.46e-05	0.0012	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MMP3—primary biliary cirrhosis	5.25e-05	0.00115	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL5—primary biliary cirrhosis	4.96e-05	0.00109	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LBR—primary biliary cirrhosis	4.66e-05	0.00102	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AGT—primary biliary cirrhosis	4.57e-05	0.001	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AGT—primary biliary cirrhosis	4.15e-05	0.00091	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL10—primary biliary cirrhosis	3.4e-05	0.000746	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—OGDH—primary biliary cirrhosis	3.37e-05	0.00074	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP3—primary biliary cirrhosis	3.1e-05	0.000681	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—TYK2—primary biliary cirrhosis	3.1e-05	0.00068	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	3.04e-05	0.000667	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PDHX—primary biliary cirrhosis	3.01e-05	0.000659	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	3e-05	0.000657	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL5—primary biliary cirrhosis	2.93e-05	0.000642	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	2.84e-05	0.000622	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DLAT—primary biliary cirrhosis	2.83e-05	0.00062	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCB4—primary biliary cirrhosis	2.83e-05	0.00062	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.6e-05	0.000571	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.46e-05	0.000539	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AGT—primary biliary cirrhosis	2.45e-05	0.000537	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	2.32e-05	0.000508	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CD80—primary biliary cirrhosis	2.17e-05	0.000476	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TYK2—primary biliary cirrhosis	1.83e-05	0.000402	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.8e-05	0.000396	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NUP210—primary biliary cirrhosis	1.7e-05	0.000372	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCG2—primary biliary cirrhosis	1.58e-05	0.000346	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—primary biliary cirrhosis	1.44e-05	0.000316	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.43e-05	0.000313	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.38e-05	0.000304	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CTGF—primary biliary cirrhosis	1.35e-05	0.000297	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GOT2—primary biliary cirrhosis	1.34e-05	0.000294	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GGT1—primary biliary cirrhosis	1.16e-05	0.000254	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GOT1—primary biliary cirrhosis	1.16e-05	0.000254	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARGC1A—primary biliary cirrhosis	1.03e-05	0.000226	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AGT—primary biliary cirrhosis	8.03e-06	0.000176	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—primary biliary cirrhosis	6.16e-06	0.000135	CbGpPWpGaD
